Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Kolon TissueGene (950160 KS)
Watchlist
16
Analysis
Health Care
•
United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Kolon Mobility Group
•
11 Aug 2025 12:06
Kolon Mobility (450140 KS)'s Delisting Offer
Trading tight to the cash terms at a 0.7%/9.8% and 0.7%/8.6% gross/annual spread for the common & preferred. The scrip terms for both are well out...
David Blennerhassett
Follow
363 Views
Share
bearish
•
Doosan Robotics
•
30 Sep 2024 21:28
End of Mandatory Lock-Up Periods for 39 Companies in Korea in October 2024
We discuss the end of the mandatory lock-up periods for 39 stocks in Korea in October 2024, among which four are in KOSPI and 35 are in KOSDAQ.
Douglas Kim
Follow
696 Views
Share
bearish
•
EcoPro Materials
•
30 Apr 2024 17:05
End of Mandatory Lock-Up Periods for 54 Companies in Korea in May 2024
We discuss the end of the mandatory lock-up periods for 54 stocks in Korea in May 2024, among which 4 are in KOSPI and 50 are in KOSDAQ.
Douglas Kim
Follow
650 Views
Share
bullish
•
GigaVis
•
11 Jan 2024 19:35
An Early Look at the Potential KOSDAQ150 Rebalance Candidates in June 2024
In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024. Potential inclusion candidates include LS Materials,...
Douglas Kim
Follow
490 Views
Share
bullish
•
AVIC International
•
21 Dec 2017 08:14
StubWorld - Set-Up & Unwind Extremes: AVIC, Kolon
This week I briefly look at: Avic International Holdings Ltd (161 HK), again, as investors take-profit while 69.7%-held subsidiary Shennan Circuits...
David Blennerhassett
Follow
702 Views
Share
Previous
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x